170 related articles for article (PubMed ID: 29555894)
1. Real-time exhaled breath analysis in patients with cystic fibrosis and controls.
Gaisl T; Bregy L; Stebler N; Gaugg MT; Bruderer T; García-Gómez D; Moeller A; Singer F; Schwarz EI; Benden C; M-L Sinues P; Zenobi R; Kohler M
J Breath Res; 2018 Apr; 12(3):036013. PubMed ID: 29555894
[TBL] [Abstract][Full Text] [Related]
2. Real-time breath analysis of exhaled compounds upon peppermint oil ingestion by secondary electrospray ionization-high resolution mass spectrometry: technical aspects.
Gisler A; Lan J; Singh KD; Usemann J; Frey U; Zenobi R; Sinues P
J Breath Res; 2020 Jul; 14(4):046001. PubMed ID: 32691749
[TBL] [Abstract][Full Text] [Related]
3. Standardization procedures for real-time breath analysis by secondary electrospray ionization high-resolution mass spectrometry.
Singh KD; Tancev G; Decrue F; Usemann J; Appenzeller R; Barreiro P; Jaumà G; Macia Santiago M; Vidal de Miguel G; Frey U; Sinues P
Anal Bioanal Chem; 2019 Jul; 411(19):4883-4898. PubMed ID: 30989265
[TBL] [Abstract][Full Text] [Related]
4. Exhaled breath analysis using electronic nose in cystic fibrosis and primary ciliary dyskinesia patients with chronic pulmonary infections.
Joensen O; Paff T; Haarman EG; Skovgaard IM; Jensen PØ; Bjarnsholt T; Nielsen KG
PLoS One; 2014; 9(12):e115584. PubMed ID: 25542036
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Ambient and Atmospheric Pressure Ion Sources for Cystic Fibrosis Exhaled Breath Condensate Ion Mobility-Mass Spectrometry Metabolomics.
Zang X; Pérez JJ; Jones CM; Monge ME; McCarty NA; Stecenko AA; Fernández FM
J Am Soc Mass Spectrom; 2017 Aug; 28(8):1489-1496. PubMed ID: 28364225
[TBL] [Abstract][Full Text] [Related]
6. Exhaled breath analysis in adult patients with cystic fibrosis by real-time proton mass spectrometry.
Mustafina M; Silantyev A; Krasovskiy S; Chernyak A; Naumenko Z; Suvorov A; Gognieva D; Abdullaev M; Bektimirova A; Bykova A; Dergacheva V; Betelin V; Kopylov P
Clin Chim Acta; 2024 Jun; 560():119733. PubMed ID: 38777246
[TBL] [Abstract][Full Text] [Related]
7. Exhaled breath profiling using broadband quantum cascade laser-based spectroscopy in healthy children and children with asthma and cystic fibrosis.
van Mastrigt E; Reyes-Reyes A; Brand K; Bhattacharya N; Urbach HP; Stubbs AP; de Jongste JC; Pijnenburg MW
J Breath Res; 2016 Apr; 10(2):026003. PubMed ID: 27058305
[TBL] [Abstract][Full Text] [Related]
8. Exhaled markers of antioxidant activity and oxidative stress in stable cystic fibrosis patients with moderate lung disease.
Spicuzza L; Parisi GF; Tardino L; Ciancio N; Nenna R; Midulla F; Leonardi S
J Breath Res; 2018 Feb; 12(2):026010. PubMed ID: 29146889
[TBL] [Abstract][Full Text] [Related]
9. Exhaled molecular profiles in the assessment of cystic fibrosis and primary ciliary dyskinesia.
Paff T; van der Schee MP; Daniels JM; Pals G; Postmus PE; Sterk PJ; Haarman EG
J Cyst Fibros; 2013 Sep; 12(5):454-60. PubMed ID: 23361110
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen cyanide concentrations in the breath of adult cystic fibrosis patients with and without Pseudomonas aeruginosa infection.
Gilchrist FJ; Bright-Thomas RJ; Jones AM; Smith D; Spaněl P; Webb AK; Lenney W
J Breath Res; 2013 Jun; 7(2):026010. PubMed ID: 23680696
[TBL] [Abstract][Full Text] [Related]
11. Volatile organic compound breath signatures of children with cystic fibrosis by real-time SESI-HRMS.
Weber R; Haas N; Baghdasaryan A; Bruderer T; Inci D; Micic S; Perkins N; Spinas R; Zenobi R; Moeller A
ERJ Open Res; 2020 Jan; 6(1):. PubMed ID: 31956658
[TBL] [Abstract][Full Text] [Related]
12. Breath concentration of acetic acid vapour is elevated in patients with cystic fibrosis.
Smith D; Sovová K; Dryahina K; Doušová T; Dřevínek P; Španěl P
J Breath Res; 2016 May; 10(2):021002. PubMed ID: 27184114
[TBL] [Abstract][Full Text] [Related]
13. Exhaled and nasal nitric oxide in relation to lung function, blood cell counts and disease characteristics in cystic fibrosis.
Krantz C; Janson C; Hollsing A; Alving K; Malinovschi A
J Breath Res; 2017 Mar; 11(2):026001. PubMed ID: 28220034
[TBL] [Abstract][Full Text] [Related]
14. Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients.
Kos R; Brinkman P; Neerincx AH; Paff T; Gerritsen MG; Lammers A; Kraneveld AD; Heijerman HGM; Janssens HM; Davies JC; Majoor CJ; Weersink EJ; Sterk PJ; Haarman EG; Bos LD; Maitland-van der Zee AH;
J Cyst Fibros; 2022 Jan; 21(1):e28-e34. PubMed ID: 34016557
[TBL] [Abstract][Full Text] [Related]
15. Analysis of human breath samples using a modified thermal desorption: gas chromatography electrospray ionization interface.
Reynolds JC; Jimoh MA; Guallar-Hoyas C; Creaser CS; Siddiqui S; Paul Thomas CL
J Breath Res; 2014 Sep; 8(3):037105. PubMed ID: 25190194
[TBL] [Abstract][Full Text] [Related]
16. Asymmetric dimethylarginine and related metabolites in exhaled breath condensate of children with cystic fibrosis.
Lucca F; Da Dalt L; Ros M; Gucciardi A; Pirillo P; Naturale M; Perilongo G; Giordano G; Baraldi E
Clin Respir J; 2018 Jan; 12(1):140-148. PubMed ID: 27216780
[TBL] [Abstract][Full Text] [Related]
17. Do linear logistic model analyses of volatile biomarkers in exhaled breath of cystic fibrosis patients reliably indicate Pseudomonas aeruginosa infection?
Španěl P; Sovová K; Dryahina K; Doušová T; Dřevínek P; Smith D
J Breath Res; 2016 Aug; 10(3):036013. PubMed ID: 27532768
[TBL] [Abstract][Full Text] [Related]
18. NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis.
Montuschi P; Paris D; Melck D; Lucidi V; Ciabattoni G; Raia V; Calabrese C; Bush A; Barnes PJ; Motta A
Thorax; 2012 Mar; 67(3):222-8. PubMed ID: 22106016
[TBL] [Abstract][Full Text] [Related]
19. Preservation of exhaled breath samples for analysis by off-line SESI-HRMS: proof-of-concept study.
Sola-Martínez RA; Zeng J; Awchi M; Gisler A; Arnold K; Singh KD; Frey U; Díaz MC; de Diego Puente T; Sinues P
J Breath Res; 2023 Dec; 18(1):. PubMed ID: 38029449
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics of volatile organic compounds in cystic fibrosis patients and controls.
Robroeks CM; van Berkel JJ; Dallinga JW; Jöbsis Q; Zimmermann LJ; Hendriks HJ; Wouters MF; van der Grinten CP; van de Kant KD; van Schooten FJ; Dompeling E
Pediatr Res; 2010 Jul; 68(1):75-80. PubMed ID: 20351658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
